I spent virtually six years in a “finance lab” harvesting it. The research concerns a certain kind of hyperbolic stock. I call them “MARKED” stocks. Warning: This brand-new research is guaranteed to violate your sensibilities. At 2 p.m. EST, I’ll reveal the power of MARKED stocks.
For the last six years, I’ve been hunting a certain kind of stock — ones virtually invisible to the naked eye. I call them “MARKED” stocks. Simply put, MARKED stocks don’t behave like ordinary stocks…
Food & Beverage
The truth might hurt, but Amazon is on track to turn Whole Foods into a tech company. Find out why in today’s article. Also, in other news, the retail carnage continues. An activist hedge fund just disclosed a large stake in the owner of Saks Fifth Avenue. The activists are already calling for Saks to go private. Is the arrival of an activist bullish for the company?
Is it possible that major insider purchases can be viewed bearishly? I asked my senior analyst, Martin Hutchinson, to tackle the merits of insider buying/selling. As it turns out, transactions must be measured on a case-by-case basis.
The recent volatility in the tech sector should act as reality check — underscoring the importance of diversifying your portfolio. So I asked senior analyst Martin Hutchinson to provide a quick rundown on the best way to approach diversification.
What happens when a videogame company tries to break into an entirely different market? And more importantly, what do you do as an investor? Check out Martin Hutchinson’s analysis on rebalancing now to find out…
With so many bullish forces at their back, uplisters tend to greatly outperform the market. In fact, they’re so mouthwatering that I asked my senior analyst, Martin Hutchinson, to drill down on uplisters. If your portfolio doesn’t include at least one uplister, you’re potentially costing yourself thousands.
Data suggest that spinoffs can possess superpowers that cause them to outperform their parent by wide margins. So I asked my senior analyst Martin Hutchinson to drill down on the subject.
IPOs are performing admirably in the first half of 2017. Only 10 of 2017’s 46 IPOs are presently under water. With nine more IPOs on the table — led by names like Yeti, Biohaven Pharmaceuticals, and G1 Therapeutics — let’s dive deeper into IPOs.
Warren Buffett believes that stock buybacks destroy shareholder value. Others think it’s a bullish sign when a company is hoarding its own shares. I asked my senior analyst, Martin Hutchinson, to give us the final word on buybacks.